409 related articles for article (PubMed ID: 38288116)
41. Nephrotic syndrome in a dish: recent developments in modeling in vitro.
Veissi S; Smeets B; van den Heuvel LP; Schreuder MF; Jansen J
Pediatr Nephrol; 2020 Aug; 35(8):1363-1372. PubMed ID: 30820702
[TBL] [Abstract][Full Text] [Related]
42. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
43. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
44. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
45. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
46. New insights into the role of podocytes in proteinuria.
Patrakka J; Tryggvason K
Nat Rev Nephrol; 2009 Aug; 5(8):463-8. PubMed ID: 19581907
[TBL] [Abstract][Full Text] [Related]
47. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
48. AMPK signalling: Implications for podocyte biology in diabetic nephropathy.
Szrejder M; Piwkowska A
Biol Cell; 2019 May; 111(5):109-120. PubMed ID: 30702162
[TBL] [Abstract][Full Text] [Related]
49. Podocyte mitosis - a catastrophe.
Lasagni L; Lazzeri E; Shankland SJ; Anders HJ; Romagnani P
Curr Mol Med; 2013 Jan; 13(1):13-23. PubMed ID: 23176147
[TBL] [Abstract][Full Text] [Related]
50. Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis.
Zhou D; Fu H; Han Y; Zhang L; Liu S; Lin L; Stolz DB; Liu Y
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31647783
[TBL] [Abstract][Full Text] [Related]
51. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
52. Effects of Perfusion Pressures on Podocyte Loss in the Isolated Perfused Mouse Kidney.
Strieder T; Puelles VG; Vogt M; Buhl EM; Saritas T; Hausmann R; Sterzer V; Leuchtle K; Boor P; Floege J; Moeller MJ; Stamellou E
Cell Physiol Biochem; 2021 Apr; 55(S4):1-12. PubMed ID: 33851800
[TBL] [Abstract][Full Text] [Related]
53. Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria.
Zuo Y; Wang C; Sun X; Hu C; Liu J; Hong X; Shen W; Nie J; Hou FF; Zhou L; Liu Y
Kidney Int; 2021 Oct; 100(4):837-849. PubMed ID: 34175352
[TBL] [Abstract][Full Text] [Related]
54. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC
Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557
[TBL] [Abstract][Full Text] [Related]
55. The role of the podocyte in albumin filtration.
Brinkkoetter PT; Ising C; Benzing T
Nat Rev Nephrol; 2013 Jun; 9(6):328-36. PubMed ID: 23609563
[TBL] [Abstract][Full Text] [Related]
56. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
[TBL] [Abstract][Full Text] [Related]
57. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.
Fukuda A; Minakawa A; Sato Y; Iwakiri T; Iwatsubo S; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2017 Nov; 32(11):1818-1830. PubMed ID: 28419296
[TBL] [Abstract][Full Text] [Related]
58. Podocyte injury and targeting therapy: an update.
Durvasula RV; Shankland SJ
Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):1-7. PubMed ID: 16340659
[TBL] [Abstract][Full Text] [Related]
59. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.
Zhang J; Pippin JW; Vaughan MR; Krofft RD; Taniguchi Y; Romagnani P; Nelson PJ; Liu ZH; Shankland SJ
Nephron Exp Nephrol; 2012; 121(1-2):e23-37. PubMed ID: 23107969
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
